1. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa (10 from 47 patents)

2. Merck Sharp + Dohme Corp. (8 from 2,405 patents)

3. Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.a. (2 from 11 patents)

4. Msd Italia S.r.l. (2 from 7 patents)

5. Irbm-science Park S.p.a. (2 from 3 patents)

6. C.n.c.c.s. Scarl Collezione Nazionale Dei Composti Chimici E Centro Screening (2 from 2 patents)

7. Merck + Co., Inc. (1 from 4,770 patents)

8. Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.p.a. (1 from 8 patents)

9. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.r.l. (1 from 4 patents)

10. Istitute Di Ricerche Di Biologia Molecolare P. Angeletti S.p.a. (1 from 2 patents)

11. Istituto Di Ricerche Di Biologia P. Angeletti S.p.a. (1 from 1 patent)

12. Antios Therapeutics, Inc. (1 from 1 patent)

13. Insituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa (1 from 1 patent)

14. Instituto Di Ricerchi Di Biologia Molecolare P. Angeletti S.p.a. (1 from 1 patent)

15. Merck Canada Inc. (40 patents)

1. 11504382 - Tricyclic inhibitors of Hepatitis B virus

2. 10815222 - Compounds for use in the treatment of kinetoplastid infection

3. 9738661 - HCV NS3 protease inhibitors

4. 9371295 - Compounds for use in the treatment of disorders that are ameliorated by inhibition of HDAC

5. 9365541 - Compounds for use in the treatment of parasitic diseases

6. 9328138 - HCV NS3 protease inhibitors

7. 8927569 - Macrocyclic compounds as antiviral agents

8. 8377873 - HCV NS3 protease inhibitors

9. 8357798 - Process for preparing N-alkylated hydroxypyrimidinone compounds

10. 8314062 - Macrocyclic compounds as antiviral agents

11. 8183216 - Nucleoside derivatives as inhibitors of viral polymerases

12. 8178520 - Macrocyclic compounds as antiviral agents

13. 8138164 - HCV NS3 protease inhibitors

14. 8080654 - Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors

15. 7981879 - HIV integrase inhibitors